Incyte Stock Current Valuation
| INCY Stock | USD 52.72 0.50 0.94% |
Valuation analysis of Incyte helps investors to measure Incyte's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value Over EBITDA is likely to rise to 12.61 in 2024. Enterprise Value Multiple is likely to rise to 12.61 in 2024. Fundamental drivers impacting Incyte's valuation include:
Price Book 2.3306 | Enterprise Value 8.3 B | Enterprise Value Ebitda 9.2204 | Price Sales 3.2716 | Forward PE 11.3895 |
Undervalued
Today
Please note that Incyte's price fluctuation is very steady at this time. Calculation of the real value of Incyte is based on 3 months time horizon. Increasing Incyte's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Incyte is useful when determining the fair value of the Incyte stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Incyte. Since Incyte is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Incyte Stock. However, Incyte's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 52.72 | Real 61.1 | Target 82.13 | Hype 52.64 | Naive 52.23 |
The real value of Incyte Stock, also known as its intrinsic value, is the underlying worth of Incyte Company, which is reflected in its stock price. It is based on Incyte's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Incyte's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Incyte's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Incyte helps investors to forecast how Incyte stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Incyte more accurately as focusing exclusively on Incyte's fundamentals will not take into account other important factors: Incyte Company Current Valuation Analysis
Incyte's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Incyte Current Valuation | 8.35 B |
Most of Incyte's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Incyte is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Incyte Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Incyte is extremely important. It helps to project a fair market value of Incyte Stock properly, considering its historical fundamentals such as Current Valuation. Since Incyte's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Incyte's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Incyte's interrelated accounts and indicators.
Click cells to compare fundamentals
Incyte Current Valuation Historical Pattern
Today, most investors in Incyte Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Incyte's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Incyte current valuation as a starting point in their analysis.
Incyte Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Incyte has a Current Valuation of 8.35 B. This is 41.89% lower than that of the Biotechnology sector and 79.66% higher than that of the Health Care industry. The current valuation for all United States stocks is 49.8% higher than that of the company.
Incyte Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Incyte's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Incyte could also be used in its relative valuation, which is a method of valuing Incyte by comparing valuation metrics of similar companies.Incyte is currently under evaluation in current valuation category among related companies.
Incyte ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Incyte's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Incyte's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Incyte Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0646 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 8.35 B | ||||
| Shares Outstanding | 224.53 M | ||||
| Shares Owned By Insiders | 1.58 % | ||||
| Shares Owned By Institutions | 98.42 % | ||||
| Number Of Shares Shorted | 8.06 M | ||||
| Price To Earning | 19.17 X | ||||
| Price To Book | 2.33 X | ||||
| Price To Sales | 3.27 X | ||||
| Revenue | 3.7 B | ||||
| Gross Profit | 1.59 B | ||||
| EBITDA | 904.74 M | ||||
| Net Income | 597.6 M | ||||
| Cash And Equivalents | 2.72 B | ||||
| Cash Per Share | 12.24 X | ||||
| Total Debt | 38.29 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.91 X | ||||
| Book Value Per Share | 23.14 X | ||||
| Cash Flow From Operations | 496.49 M | ||||
| Short Ratio | 4.27 X | ||||
| Earnings Per Share | 2.65 X | ||||
| Price To Earnings To Growth | 0.69 X | ||||
| Target Price | 75.35 | ||||
| Number Of Employees | 2.52 K | ||||
| Beta | 0.67 | ||||
| Market Capitalization | 11.95 B | ||||
| Total Asset | 6.78 B | ||||
| Retained Earnings | 160.38 M | ||||
| Working Capital | 3.41 B | ||||
| Current Asset | 842.38 M | ||||
| Current Liabilities | 168.01 M | ||||
| Net Asset | 6.78 B |
About Incyte Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Incyte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Incyte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Incyte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Incyte Piotroski F Score and Incyte Altman Z Score analysis. For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Complementary Tools for Incyte Stock analysis
When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.324 | Earnings Share 2.65 | Revenue Per Share 16.526 | Quarterly Revenue Growth 0.093 | Return On Assets 0.0646 |
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.